Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
Recent drug discovery and development efforts have created a large arsenal of targeted and chemotherapeutic drugs for precision medicine. However, drug resistance remains a major challenge as minor pre-existing resistant subpopulations are often found to be enriched at relapse. Current drug design h...
Main Authors: | Sun, Daphne S., Dalin, Simona, Hemann, Michael, Lauffenburger, Douglas A, Zhao, Boyang |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/109785 https://orcid.org/0000-0001-5024-9718 https://orcid.org/0000-0003-4610-1707 |
Similar Items
-
Intratumor heterogeneity alters most effective drugs in designed combinations
by: Zhao, Boyang, et al.
Published: (2015) -
Modeling Tumor Clonal Evolution for Drug Combinations Design
by: Zhao, Boyang, et al.
Published: (2018) -
Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
by: Zhao, Boyang, et al.
Published: (2014) -
Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse
by: Dalin, Simona, et al.
Published: (2022) -
Application of the single cell genomics in deciphering tumor heterogeneity and its role in tumor progression and drug resistance
by: Marjanovic, Nemanja.
Published: (2021)